Eliminating Trachoma in Areas with Limited Disease - Wikidata - wikimedia - TriplyDB

Eliminating Trachoma in Areas with Limited Disease

Eliminating Trachoma in Areas with Limited Disease

http://www.wikidata.org/entity/Q29037878

about

sameAs

Trachoma: an update on prevention, diagnosis, and treatment Transmission of chronic wasting disease identifies a prion strain causing cachexia and heart infection in hamsters Atomic Structures Suggest Determinants of Transmission Barriers in Mammalian Prion Disease Mass drug administration for trachoma: how long is not long enough?Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program Molecular Mechanisms of Chronic Wasting Disease Prion Propagation.A rationale for continuing mass antibiotic distributions for trachoma Direct detection of soil-bound prions.Host PrP glycosylation: a major factor determining the outcome of prion infection.Reduction and return of infectious trachoma in severely affected communities in Ethiopia.When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries Infectious prions in pre-clinical deer and transmission of chronic wasting disease solely by environmental exposure Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution Chronic wasting disease agents in nonhuman primates.Transmission of scrapie and sheep-passaged bovine spongiform encephalopathy prions to transgenic mice expressing elk prion protein.Experimental oral transmission of chronic wasting disease to red deer (Cervus elaphus elaphus): early detection and late stage distribution of protease-resistant prion protein.Susceptibilities of nonhuman primates to chronic wasting disease.Application of "omics" to prion biomarker discovery.Elimination of active trachoma after two topical mass treatments with azithromycin 1.5% eye drops.Chronic wasting disease.Experimental oral transmission of chronic wasting disease to reindeer (Rangifer tarandus tarandus)Immunomodulation for prion and prion-related diseases.Alimentary prion infections: Touchdown in the intestine.Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein.Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.Seeded fibrillation as molecular basis of the species barrier in human prion diseases.Transmission of elk and deer prions to transgenic mice Prion disease induced alterations in gene expression in spleen and brain prior to clinical symptoms.The distribution of ocular Chlamydia prevalence across Tanzanian communities where trachoma is declining The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.Topical ocular antibiotics induce bacterial resistance at extraocular sites.Human prion disease and relative risk associated with chronic wasting disease.Chronic wasting disease of elk and deer and Creutzfeldt-Jakob disease: comparative analysis of the scrapie prion protein Confronting zoonoses, linking human and veterinary medicine.Could immunomodulation be used to prevent prion diseases?Wildlife as source of zoonotic infections.Use of a 2-aminothiazole to Treat Chronic Wasting Disease in Transgenic Mice Surveillance for prion disease in cervids, Germany.Gene expression alterations in Rocky Mountain elk infected with chronic wasting disease.Association mapping of genetic risk factors for chronic wasting disease in wild deer

P2860

Q26825233-6F5EA381-4DC7-498D-B132-A35C42DFA022 Q27311657-001315D5-B3EF-4A50-9862-D35C92CF2966 Q27666974-89AC7C6A-FB15-4565-B8CE-27ECB60BB5D4 Q28544875-E7E79F96-5490-430C-8F0C-ABAA73647E38 Q28550184-2CDA62CB-CFB1-447F-9833-52862DDA17C8 Q31161627-C20E2A7C-7795-4641-93C8-F0FF030B6B8D Q33293477-74813DA4-B716-4A4A-9158-CA57C353336A Q33303678-80CD8F14-24F2-47A9-933E-497F02E511DD Q33328636-CF562012-C760-4203-ADD2-04D84DAB66FF Q33405255-17A90442-A21A-4523-A37C-732146040FB0 Q33468389-4C958F65-36F3-4772-9BDF-AD40D1A10F19 Q33468412-4DC8C041-A2A8-4C1E-A591-298491992E3C Q33496749-1DD08263-9BB6-456B-AA6D-2491DA9D1D00 Q33577115-69C37BC8-B4BE-4F07-8AB9-0D60A2F5EAA5 Q33580805-0861352B-6316-455C-83ED-A6D9CBE83472 Q33598070-91768659-216C-4782-BB3B-C55A971EA3E3 Q33644675-50D6774E-66A6-4709-A7BF-35FD47B58B54 Q33708360-A15798E2-D118-4BFF-B6C5-1BB26FD21D45 Q33761058-0A85DAAE-7E48-4C40-8373-170BD3EDAAE3 Q34001936-B6F15700-65E7-4CDA-BBDB-FBBA8D47E832 Q34283527-903D4A58-005D-430C-866D-CE38BAF2E37B Q34565644-B8D13E6A-0A6E-4925-9CFC-73A5594BB48E Q34570017-E2D3A48B-2D11-488C-9E09-94D7B4122125 Q34641947-01D649F5-9346-4246-AA0C-6F4BBEA52C3A Q34855220-6963E898-9901-405A-83DE-B037740ED271 Q34973982-9FECBE4A-1D42-480D-965A-9E412EB3D071 Q35024303-982B48C0-FBCA-4A3B-95DC-48B93F8A0611 Q35205306-8DFBB808-0BEB-495D-BC7D-D9C77E5B2054 Q35223739-9B5D66E3-DFF1-461E-B659-5E2064DC502A Q35571651-D771F3AC-E35F-42CF-BDE2-20A17FDCBE92 Q35593627-1AFC0990-C2E2-40BF-A9D5-CD1386264CEA Q35792137-82B5C71A-33E5-4ABB-A0ED-C27BDF081EF4 Q35794889-1A732110-1A19-4B32-A28F-ED15E1630D25 Q35805578-5F260194-223E-4114-8655-0B8E94684AC6 Q35875915-49BD98CE-AEAF-4771-9951-EB37A31CB358 Q35881114-E8710DF6-9E2F-409A-952E-BB316FDE9A27 Q35999953-6B1F1E8F-932C-49B9-A91E-A9A2F210E5D2 Q36026381-411F97B6-96AB-41EC-8254-611992F0D605 Q36102481-B3A1FDFC-AA56-48F9-AA57-A609167C32A2 Q36651717-4FBAF453-A0ED-444A-9B4C-BB1DB74EC5FC

P2860

Eliminating Trachoma in Areas with Limited Disease

http://www.wikidata.org/entity/Q29037878

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Eliminating Trachoma in Areas with Limited Disease

@ast

Eliminating Trachoma in Areas with Limited Disease

@en

type

label

Eliminating Trachoma in Areas with Limited Disease

@ast

Eliminating Trachoma in Areas with Limited Disease

@en

altLabel

Eliminating trachoma in areas with limited disease

@en

prefLabel

Eliminating Trachoma in Areas with Limited Disease

@ast

Eliminating Trachoma in Areas with Limited Disease

@en

P1433

Q29037878-A9B4F8DC-E901-4AF8-A779-969713379250

P1476

Q29037878-3573FD47-E0F5-44AD-94CE-A3EF9E581C47

Q29037878-CF9C30DC-E19C-4A92-BF2C-7D6C66B16B35

P2093

Q29037878-24C0C20D-D6FE-4C0F-9A7D-347E572EEEE1

Q29037878-24D65255-7D3D-4446-BDF3-7B174A8DDB9F

Q29037878-2CEFBF4F-E3F0-4D4F-A9C5-B21F076D52BA

Q29037878-3FE09A00-D650-49AE-AEEC-9FE0A0199DA1

Q29037878-48539E0E-97FF-448B-AACA-78E478466CD3

Q29037878-54A6245D-605E-470C-92E4-5E23DE76FAA3

Q29037878-5D67F298-BCB6-4A8C-B52B-BDC032581762

Q29037878-80D49FDD-6A0D-4DBF-9A75-C87A9DFDD03A

Q29037878-906F9DAE-7CFD-4C82-8040-C30EF2619DAF

Q29037878-9217B661-9A7A-40A4-B34F-B1DAF661A438

P2860

Q29037878-060190BF-FFDE-4D21-9DD0-33D7981ECFD2

Q29037878-2A83988C-3A9D-4300-ADE4-919D571FC463

Q29037878-2BB51744-E580-476F-954B-91990DFD91E9

Q29037878-3AE014DC-EBC8-49BF-A697-21325EA1CAB4

Q29037878-5DD430A2-EB20-4631-84EE-6B2C9439AA99

Q29037878-671CE06F-E173-4C58-B446-65292EA88677

Q29037878-87158B1E-A3BC-4976-A364-097E4FF04C9F

Q29037878-B6FDAD92-1E85-4DD9-A939-738C0A2D2205

Q29037878-BD7CAF2F-047F-4DE0-8D94-895D2DF21C99

Q29037878-C1CFBCD5-E966-459B-B60E-DA995923DC99

P304

Q29037878-B9640F52-41CB-43C0-9C55-A1DBEAAA939B

P31

Q29037878-B77A5804-6790-480C-A29C-9A443578DD34

P356

Q29037878-6CA294E0-A46C-45EC-9CA6-D837F1E6A295

P433

Q29037878-08BFEF6F-2CC8-4BF1-BF49-1125448FE5F7

P478

Q29037878-5A06FD53-96CE-42E8-893B-FE54BAD1DDF9

P577

Q29037878-881FE119-F656-4B13-BB00-14610EA0261D

Q29037878-AA25BA2E-B50B-448D-8807-03F4F192732B

P5875

Q29037878-8BDFE491-A13D-4A71-AEFE-3E3BDD51A862

P698

Q29037878-603E1B19-57B1-420D-BB73-104352A2B820

Q29037878-D7F3F6A6-06E4-4F24-BA03-F2D2D3CF9980

P932

Q29037878-9A69B40F-A8BD-48AE-A6AE-C52D9C380DF2

P356

P1433

Emerging Infectious Diseases

P1476

Eliminating Trachoma in Areas with Limited Disease

@en

Eliminating trachoma in areas with limited disease

@en

P2093

Bruce D Gaynor

http://www.w3.org/2001/XMLSchema#string

Bruce D. Gaynor

http://www.w3.org/2001/XMLSchema#string

Elizabeth Yi

http://www.w3.org/2001/XMLSchema#string

Hem Jha

http://www.w3.org/2001/XMLSchema#string

J S P Chaudary

http://www.w3.org/2001/XMLSchema#string

JSP Chaudary

http://www.w3.org/2001/XMLSchema#string

John P Whitcher

http://www.w3.org/2001/XMLSchema#string

John P. Whitcher

http://www.w3.org/2001/XMLSchema#string

Julius Schachter

http://www.w3.org/2001/XMLSchema#string

Ramesh Bhatta

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal

The principles of disease elimination and eradication.

Rationale for mass antibiotic distribution for trachoma elimination.

Report of the Workgroup on Bacterial Diseases.

Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of Nepal

Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?

Azithromycin in control of trachoma.

Randomised controlled trial of single-dose azithromycin in treatment of trachoma.

Conference synthesis and vision for the future.

Global elimination of trachoma: how frequently should we administer mass chemotherapy?

P304

596-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID0905.020577

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10767765

http://www.w3.org/2001/XMLSchema#string

P698

12737745

http://www.w3.org/2001/XMLSchema#string

15207045

http://www.w3.org/2001/XMLSchema#string

P932

2972764

http://www.w3.org/2001/XMLSchema#string